//
					
					
				
										
										
										
										
										
										
										
										Myeloid-Derived Growth Factor Protects Against Pressure Overload–Induced Heart Failure by Preserving Sarco/Endoplasmic Reticulum Ca2+-ATPase Expression in Cardiomyocytes
The Evolution of β-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5)
Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced Trial
Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators
Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators - The RAID Trial
Positive recommendation for angiotensin receptor/neprilysin inhibitor: First medication approval for heart failure without "reduced ejection fraction"
Stage B heart failure: management of asymptomatic left ventricular systolic dysfunction
Association of Reduced Apical Untwisting With Incident HF in Asymptomatic Patients With HF Risk Factors